CLINICAL FOCUS SESSION
Liver Contrast Agents

Room A201
13:30 – 15:30

Chairs: Philip J. Robinson, Keynote Speaker, and Janice Ward

13:30   Keynote.
13:45   202.  Multicenter Phase III Trial of Gadodiamide and Gadopentetate-Dimeglumine in MRI Versus Dual Phase Spiral-CT in the Diagnosis of Liver Lesions, H-U. Kauczor, C.P. Heussel, L. Marti-Bonmati, C. L'Hermine, G. Schmutz, P. Chevallier, S. Olliff, P.A. Kane, G. Jung, T. Kittner, C. Matos, B. van Beers, R. Loose, M. Lenz, K. Meurer and M. Thelen, European Multicenter Group, Mainz, Germany.
13:57   203.  Volumetric Interpolated Isotropic 3D MR Imaging Versus Digital Subtraction Angiography in the Evaluation of Hepatic Arterial Anatomy, M.T. Lavelle, V.S. Lee, G.A. Krinsky, J.C. Weinreb and N.M. Rofsky, New York University, New York, NY, USA.
14:09   204.  Simultaneous Acquisition of In-Phase and Opposed Phase Dynamic MR Imaging for Assessment of Focal Lesions in Cirrhotic Liver, J-S. Yu, K.W. Kim, J-G. Park, E-K. Jeong and D. Chien, Yonsei University College of Medicine, Seoul, South Korea and Siemens AG, Erlangen, Germany.
14:21   205.  MRI in Focal Hepatic Disease: A Comparison of Gd-DTPA and Ferumoxides-enhanced MRI in over 900 patients, T. Helmberger, N. Holzknecht, M. Gregor, B. Knuth, R. Stangl, S. Banac, B. Scher, J. Scheidler and M. Reiser, Ludwig-Maxmilians-University, Munich, Germany.
14:33   206.  Diagnostic Efficacy of Contrast-Enhanced Spiral CT, Unenhanced and Gd-DTPA and Ferumoxides-enhanced MRI in the same Patient Population With Focal Liver Disease, N. Holzknecht, T. Helmberger, M. Gregor, B. Knuth, R. Stangl, S. Banac, B. Scher, J. Scheidler and M. Reiser, Ludwig-Maximilians-University, Munich, Germany.
14:45   207.  The Impact of Reduced Dose SPIO on the Detection of Colorectal Liver Metastases: A Quantitative and Qualitative Analysis, D.J. Scott, J. Ward, J.A. Guthrie, D. Wilson and P.J. Robinson, St James's University Hospital, Leeds, UK.
14:57   208.  Superparamagnetic Iron Oxide-Enhanced MR Imaging for the Detection and Characterization of Hepatic Tumors: Do We Really Need a Precontrast Study?   J.M. Lee, H.S. Kwak and C-S. Kim, Chonbuk National University Hospital, Chonbuk, Korea.
15:09   209.  Better Liver Lesion Diagnosis with Mangafodipir Trisodium (MnDPDP)-Enhanced MR Liver Imaging: A Multicenter Study Comparing MR and Biphasic Spiral CT, M. Oudkerk, P. van Dijk, M. König, J. Grimm, B.O. de Beeck, J. Fernandez-Cuadrado, M. Roddie, B. Song and C.G. Torres, University Hospital Rotterdam, Rotterdam, The Netherlands; Nycomed Amersham, Oslo, Norway; Ruhr-University Clinic, Bochum, Germany; Christian-Albrechts University, Kiel, Germany; Free University Hospital (VUB), Brussels, Belgium; Hospital La Paz, Madrid,Spain and Charing Cross Hospital, London, UK.

Return to ISMRM program